• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins

tetano

Editor, Senior Moderator
PLoS Biol


. 2020 Dec 21;18(12):e3001016.
doi: 10.1371/journal.pbio.3001016. eCollection 2020 Dec.
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins


Carina Conceicao[SUP] 1 [/SUP], Nazia Thakur[SUP] 1 [/SUP], Stacey Human[SUP] 1 [/SUP], James T Kelly[SUP] 1 [/SUP], Leanne Logan[SUP] 1 [/SUP], Dagmara Bialy[SUP] 1 [/SUP], Sushant Bhat[SUP] 1 [/SUP], Phoebe Stevenson-Leggett[SUP] 1 [/SUP], Adrian K Zagrajek[SUP] 1 [/SUP], Philippa Hollinghurst[SUP] 1 2 [/SUP], Michal Varga[SUP] 1 [/SUP], Christina Tsirigoti[SUP] 1 [/SUP], Matthew Tully[SUP] 1 [/SUP], Chris Chiu[SUP] 1 [/SUP], Katy Moffat[SUP] 1 [/SUP], Adrian Paul Silesian[SUP] 1 [/SUP], John A Hammond[SUP] 1 [/SUP], Helena J Maier[SUP] 1 [/SUP], Erica Bickerton[SUP] 1 [/SUP], Holly Shelton[SUP] 1 [/SUP], Isabelle Dietrich[SUP] 1 [/SUP], Stephen C Graham[SUP] 3 [/SUP], Dalan Bailey[SUP] 1 [/SUP]



Affiliations

Abstract

SARS Coronavirus 2 (SARS-CoV-2) emerged in late 2019, leading to the Coronavirus Disease 2019 (COVID-19) pandemic that continues to cause significant global mortality in human populations. Given its sequence similarity to SARS-CoV, as well as related coronaviruses circulating in bats, SARS-CoV-2 is thought to have originated in Chiroptera species in China. However, whether the virus spread directly to humans or through an intermediate host is currently unclear, as is the potential for this virus to infect companion animals, livestock, and wildlife that could act as viral reservoirs. Using a combination of surrogate entry assays and live virus, we demonstrate that, in addition to human angiotensin-converting enzyme 2 (ACE2), the Spike glycoprotein of SARS-CoV-2 has a broad host tropism for mammalian ACE2 receptors, despite divergence in the amino acids at the Spike receptor binding site on these proteins. Of the 22 different hosts we investigated, ACE2 proteins from dog, cat, and cattle were the most permissive to SARS-CoV-2, while bat and bird ACE2 proteins were the least efficiently used receptors. The absence of a significant tropism for any of the 3 genetically distinct bat ACE2 proteins we examined indicates that SARS-CoV-2 receptor usage likely shifted during zoonotic transmission from bats into people, possibly in an intermediate reservoir. Comparison of SARS-CoV-2 receptor usage to the related coronaviruses SARS-CoV and RaTG13 identified distinct tropisms, with the 2 human viruses being more closely aligned. Finally, using bioinformatics, structural data, and targeted mutagenesis, we identified amino acid residues within the Spike-ACE2 interface, which may have played a pivotal role in the emergence of SARS-CoV-2 in humans. The apparently broad tropism of SARS-CoV-2 at the point of viral entry confirms the potential risk of infection to a wide range of companion animals, livestock, and wildlife.
 
Back
Top Bottom